Clinical Trials Logo

Filter by:
NCT ID: NCT00122382 Completed - Clinical trials for Rheumatoid Arthritis

Remission and Joint Damage Progression in Early Rheumatoid Arthritis

Start date: July 2005
Phase: Phase 3
Study type: Interventional

This is a world wide study to evaluate the remission and joint damage in subjects treated with abatacept in addition to methotrexate versus subjects who receive methotrexate along with a placebo.

NCT ID: NCT00122330 Completed - Clinical trials for Hemoglobinuria, Paroxysmal

Study Using Eculizumab in Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients

Start date: October 2004
Phase: Phase 3
Study type: Interventional

The primary objective is to evaluate the safety and efficacy of eculizumab in transfusion dependent patients with hemolytic PNH.

NCT ID: NCT00122317 Completed - Clinical trials for Paroxysmal Hemoglobinuria, Nocturnal

Extension Study of Eculizumab in Patients With Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH)

Start date: May 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the long-term safety of eculizumab in patients with transfusion dependent hemolytic PNH.

NCT ID: NCT00122304 Completed - Clinical trials for Hemoglobinuria, Paroxysmal

Study of Safety in Hemolytic Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated With Eculizumab

Start date: December 2004
Phase: Phase 3
Study type: Interventional

The primary objective is to evaluate the safety of eculizumab in patients with transfusion-dependent hemolytic PNH

NCT ID: NCT00119717 Completed - Clinical trials for Cerebrovascular Accident

Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke (SENTIS)

SENTIS
Start date: June 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the safety and efficacy of the NeuroFlo™ catheter for use in patients with ischemic stroke. The NeuroFlo device is intended to increase blood flow to the brain and potentially reduce the damage caused by stroke.

NCT ID: NCT00119678 Completed - Clinical trials for Systemic Lupus Erythematosus

Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisone

Start date: September 2005
Phase: Phase 2
Study type: Interventional

The purpose of this clinical research study is to learn whether Abatacept can treat and prevent lupus flares; specifically, in patients with active lupus flares in at least one of three organ systems: skin (discoid lesions); inflammation of the lining of the heart (pericarditis), or inflammation of the lining of the lung (pleuritis/pleurisy); or inflammation of more than 4 joints (arthritis). All participants will receive prednisone or prednisone-equivalent treatment in combination with study medication. The safety of this treatment will also be studied.

NCT ID: NCT00119470 Completed - Lung Cancer Clinical Trials

EUS-FNA in the Pre-Operative Evaluation of Patients With Lung Cancer

Start date: February 2005
Phase: Phase 2
Study type: Interventional

This trial examines the role of EUS-FNA (Oesophageal Endoscopic Ultrasound with Fine Needle Aspiration) as an endoscopic technique for the mediastinal staging of patients with lung cancer. Patients will be randomized to either conventional surgical technique or EUS-FNA.

NCT ID: NCT00117780 Completed - Diabetes Clinical Trials

Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 Diabetes

ADAPT
Start date: June 2005
Phase: Phase 4
Study type: Interventional

This trial is conducted in Europe. The aim of this research study is to compare the efficacy (reduction in HbA1c and in blood glucose levels) of insulin detemir once daily injection compared to insulin detemir twice daily injection administered as basal insulin for the treatment of type 1 diabetes and to verify the safety of use (number and severity of episodes of hypoglycemia, body weight and side effects).

NCT ID: NCT00117598 Completed - Lymphoma Clinical Trials

Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)

OPTIMAL
Start date: May 2005
Phase: Phase 3
Study type: Interventional

This is an open-label, randomized trial in relapsed refractory subjects with mantle cell lymphoma (MCL).

NCT ID: NCT00117390 Completed - Critical Illness Clinical Trials

Evaluation of the Optimal Technique for Determination of Renal Function of Critically Ill Patients

Start date: June 2004
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the optimal technique for determination of the renal function of critically ill patients.